Jake Lombardo
CEO & Co-Founder
Anodyne Nanotech
Bio:
Jake Lombardo has been Co-Founder and CEO at Anodyne since its inception in early 2019, leading the company through its first successful clinical trial and into clinical development for its lead GLP-1 asset. He brings a unique combination of biomedical engineering expertise and entrepreneurial acumen. Under his leadership, Anodyne has also secured substantial venture capital funding and advanced from concept to a platform company developing multiple, next-generation cardiometabolic treatments.
He holds a B.S. in Biomedical Engineering from Union College and an M.Sc. in Innovation and Management from Tufts University. Jake is also one of the key inventors of Anodyne’s proprietary technology.